AstraZeneca seeks U.S. FDA authorisation of drug to prevent COVID-19

AstraZeneca seeks U.S. authorisation of drug to prevent COVID-19 AstraZeneca has requested emergency use authorisation from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system. Ludwig Burger,Sachin Ravikumar Reuters

Oct 5 (Reuters) - AstraZeneca (AZN.L) has requested emergency use authorisation from U.S. regulators for its new treatment to prevent COVID-19 for people who respond poorly to vaccines because of a weakened immune system.

In a statement on Tuesday, the Anglo-Swedish drugmaker said it included data in its filing with the Food and Drug Administration from a late-stage trial that showed the drug reduced the risk of people developing any COVID-19 symptoms by 77%. ...